BORGIA, GUGLIELMO
 Distribuzione geografica
Continente #
NA - Nord America 2.992
EU - Europa 1.595
AS - Asia 593
AF - Africa 57
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
OC - Oceania 1
Totale 5.244
Nazione #
US - Stati Uniti d'America 2.850
IT - Italia 575
CN - Cina 547
NL - Olanda 291
FI - Finlandia 183
IE - Irlanda 169
DE - Germania 142
CA - Canada 140
UA - Ucraina 94
CI - Costa d'Avorio 49
GB - Regno Unito 49
SE - Svezia 42
CH - Svizzera 18
FR - Francia 17
IN - India 14
SG - Singapore 10
EG - Egitto 8
TR - Turchia 7
IR - Iran 4
EU - Europa 3
RS - Serbia 3
VN - Vietnam 3
BE - Belgio 2
BG - Bulgaria 2
BR - Brasile 2
LU - Lussemburgo 2
MX - Messico 2
PH - Filippine 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
CL - Cile 1
ES - Italia 1
ID - Indonesia 1
JP - Giappone 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MK - Macedonia 1
RO - Romania 1
RU - Federazione Russa 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 5.244
Città #
Chandler 606
Amsterdam 282
Millbury 282
Princeton 198
Nanjing 188
Naples 167
Ottawa 136
Jacksonville 114
Napoli 104
Ashburn 102
Beijing 90
Boston 90
Des Moines 85
Wilmington 69
Nanchang 64
Hebei 40
Jiaxing 38
Ann Arbor 33
Shenyang 33
Krefeld 31
Woodbridge 31
Lawrence 28
Houston 27
Tianjin 26
Norwalk 21
Changsha 18
Basel 17
Indiana 14
Seattle 12
Falls Church 11
Caserta 10
Boardman 8
Hangzhou 8
Pomigliano D'arco 8
Boise 7
Dublin 7
Kunming 7
Changchun 6
Kronberg 6
Orange 6
Redmond 6
Washington 6
Fisciano 5
Jinan 5
New York 5
Pune 5
Singapore 5
Bologna 4
Brescia 4
Cairo 4
Castellammare di Stabia 4
Agropoli 3
Bari 3
Campagna 3
Cercola 3
Chicago 3
Dung 3
Edinburgh 3
Guangzhou 3
Lanzhou 3
Milan 3
Mumbai 3
Palermo 3
Redwood City 3
Richland 3
Rome 3
Shenzhen 3
Acquaviva Delle Fonti 2
Augusta 2
Chions 2
Cologno Monzese 2
Fremont 2
Gualtieri 2
Maricopa 2
Marigliano 2
Mountain View 2
Pozzuoli 2
Richmond 2
San Prisco 2
Sennori 2
Serra 2
Sesto San Giovanni 2
Shanghai 2
Simi Valley 2
Sorrento 2
Spoleto 2
Torino 2
Torre Annunziata 2
Torre Del Greco 2
Vittorio Veneto 2
Walnut 2
Zhengzhou 2
Acerra 1
Afragola 1
Ardabil 1
Astana 1
Aversa 1
Belgrade 1
Brussels 1
Buffalo 1
Totale 3.189
Nome #
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 129
Hemolytic anemia during pegylated interferon alpha 2b plus ribavirin treatment for chronic hepatitis C: ribavirin is not always the culprit. A case report 71
CpG and Toll-like receptor 9 in primary biliary cirrhosis: a possible intracellular interaction from virus exposure? 60
CD4+ T lymphocytes and cryoglobulins in patients coinfected with HIV and hepatitis C virus: forgetting the hidden CD4+ cell subsets. 56
Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy 56
The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C 55
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 54
HIV and hepatitis C virus: facts and controversies 51
Human Platelet Antigen Genotypes As Predictors of Liver Cirrhosis In Patients With Hcv Chronic Infection 51
Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art 50
Discontinued drugs in 2012 - 2013: Hepatitis C virus infection 49
A survey on antibiotic therapy knowledge among physicians of a tertiary care and university hospital 47
A SIMPLE NONINVASIVE SCORE PREDICTS GASTROESOPHAGEAL VARICES IN PATIENTS WITH CHRONIC VIRAL HEPATITIS. 45
Rara e grave manifestazione dell’infezione da HHV-6: la sindrome DRESS. 45
A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C 45
Asunaprevir for hepatitis C: A safety evaluation 45
Human Platelet Antigen 3 Genotype Is An Independent Predictor of Platelet Count In Patients With Chronic Hepatitis C 44
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection 43
Does compulsory vaccination limit personal freedom? Ethical issues 43
A Novel Promising Therapeutic Option Against Hepatitis C Virus: An Oral Nucleotide NS5B Polymerase Inhibitor Sofosbuvir 41
Current and emerging pharmacotherapy for the treatment of bacterial peritonitis 41
Antibiotic prophylaxis and risk of infections in thyroid surgery: Results from a national study (UEC - Italian Endocrine Surgery Units Association) 40
Low vitamin D levels are associated with the presence of serum cryoglobulins in patients with chronic HCV infection 40
The serum-ascites vitamin D gradient (SADG): A novel index in spontaneous bacterial peritonitis 40
Human immunodeficiency virus and subtype 1B hepatitis C virus: more similarities than differences in T-helper subsets. 38
TNF-alpha serum level elevations in chronic hepatitis C patients with diabetes mellitus. 37
Specific immunoglobulin against HCV: new perspectives. 37
Blood letting therapy in HCV-related iron overload - Part 1: Evaluation of clinical, hematological and hepatic parameters 37
Blood In Saliva of Patients With Acquired-immunodeficiency-syndrome - Possible Implication In Sexual Transmission of the Disease 37
ABT-450: A novel protease inhibitor for the treatment of hepatitis C virus infection 37
Hepatitis C screening in the Emergency Department of a large hospital in southern Italy: results of a pilot study 37
The efficacy and safety of telaprevir - a new protease inhibitor against hepatitis C virus. 36
Human platelet antigen 3 genotype predicts platelet count in patients with HCV infection 36
Beclabuvir for the treatment of hepatitis C 35
Studio sulla conoscenza dell’antibioticoterapia tra i medici di un ospedale universitario di terzo livello 35
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 35
Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort) 35
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 34
Compromissione cognitiva subclinica in pazienti HCV-positivi 34
Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: Results from a prospective study 34
HCV and GBV-c/HGV infection in HIV positive patients in southern Italy. 33
Immunoglobulin superantigen protein L induces IL-4 and IL-13 secretion from human Fc epsilon RI+ cells through interaction with the kappa light chain of IgE 33
Mutante lamivudino-resistente in paziente in profilassi con lamivudina in corso di chemioterapia antiblastica per linfoma non-Hodgkin: recupero clinico con terapia di associazione lamivudina e adefovir. 33
Current evidence on the management of hepatitis B in pregnancy 33
Exposure to Varicella Zoster Virus is higher in children with autism spectrum disorder than in healthy controls. Results from a case-control study. 33
Fecal microbiota transplantation for Clostridium difficile infection: Back to the future 33
Direct acting antiviral agents and hepatocellular carcinoma development: Don't take it for granted 33
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 33
Homocysteine levels and sustained virological response to pegylated-interferon alpha2b plus ribavirin therapy for chronic hepatitis C: a prospective study. 32
A CASE OF PEGYLATED INTERFERON ALPHA-RELATED DIABETIC KETOACIDOSIS: CAN THIS COMPLICATION BE AVOIDED? 32
Human immunodeficiency virus per se exerts atherogenic effects. 32
Blood letting therapy in HCV-related iron overload - Part 2: Evaluation of HFE genetic mutation, HCV genotype and viral load 32
Investigational direct-acting antivirals in hepatitis C treatment: The latest drugs in clinical development 32
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 32
Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis 32
Blood in saliva of HIV seropositive drug abusers: possible implication in AIDS transmission. 31
Aetiological association of virus like particles with hepatitis C. 31
Detection of Hepatitis-c Virus-rna By Polymerase Chain-reaction In Dental Surgeries 31
Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C. 31
Prevalenza di infezioni da CMV, HHV-6 o EBV in bambini con disturbi dello spettro autistico. 31
Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection. 31
A pill a day keeps HCV away 31
Concomitant Interferon-alfa and chemotherapy in hepatitis C and colorectal cancer: a case report 30
Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A 30
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 30
Epidemiology and Microbiology of Skin and Soft Tissue Infections: Preliminary Results of a National Registry 30
Immune system homeostasis during acute hepatitis C: viral escape or T-cell regulation? 29
Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial. 29
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 29
Prevalence of HSV1/2 congenital infection assessed through genome detection on dried blood spot in individuals with autism spectrum disorders 29
Diffusione dell'infezione da virus epatitico B in ambiente odontoiatrico 28
[Demonstration of the interchangeability of 2 types of recombinant anti-hepatitis-B vaccine]. 28
[Effect of cocaine administration on experimental hepatitis in the mouse caused by MHV-3 virus: preliminary results]. 28
Prevalence of circulating immunecomplexes and variations of complement fractions in HBV, HDV and HCV infections: statistical analysis and clinical correlations. 28
Decreased warfarin effects in elder with recurrent Clostridium difficile infection during fidaxomicin therapy: a case report 28
Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis 28
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naive for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014 28
Multivariate discriminant function based on six biochemical markers in blood can predict the cirrhotic evolution of chronic hepatitis. 27
Uno score non invasivo può predire la presenza di varici gastroesofagee nei pazienti con epatopatia cronica virale. 27
Iron depletion before HCV antiviral therapy: A pilot, randomized, controlled trial. 27
Acute hepatitis C in patients undergoing hemodialysis: experience with high-dose interferon therapy 27
The therapeutic potential of new investigational hepatitis C virus translation inhibitors 27
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens 27
Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn's disease 27
Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis C. 26
Long-term interferon-alpha therapy does not affect sex hormones in males with chronic hepatitis C. 26
Febbre di origine sconosciuta (FUO): nostra casistica 26
Contaminazione da HBsAg (antigene di superficie del virus epatitico B) in ambiente odontoiatrico 26
Secondary hemosiderosis, iron depletion and hepatitis C viral load 26
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 26
Prevalence of Congenital Cytomegalovirus Infection Assessed Through Viral Genome Detection in Dried Blood Spots in Children with Autism Spectrum Disorders 26
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 26
A case of paracoccidioidomycosis: Experience with long-term therapy 25
[Clinical and diagnostic considerations on a case of pancreatic plasmacytoma]. 25
[Effect of the administration of Cardiostenol on experimental hepatitis in mice induced with MHV-3 virus]. 25
Sustained low influenza vaccination in health care workers after H1N1 pandemic: A cross sectional study in an Italian health care setting for at-risk patients 25
Hepatitis B mother-to-child transmission and infants immunization: we have not come to the end of the story yet 25
Infections worsen prognosis of patients with cirrhosis irrespective of the liver disease stage 25
Modeling cost-effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real-life cohort 25
Pernicious anemia during IFN-alpha treatment for chronic hepatitis C 24
Totale 3.548
Categoria #
all - tutte 22.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.580


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201937 0 0 0 0 0 0 0 0 0 3 3 31
2019/2020680 333 11 23 9 47 5 3 6 6 43 114 80
2020/2021350 29 22 37 24 37 70 30 3 36 18 32 12
2021/20221.113 5 3 0 6 4 31 5 38 176 79 210 556
2022/20231.705 234 86 24 135 162 182 13 241 254 287 57 30
2023/2024666 35 160 217 40 35 64 19 85 9 2 0 0
Totale 5.534